A critical appraisal of sedation, analgesia and delirium in neurocritical care

Canadian Journal of Neurological Sciences

Volumn 38, Issue 6, 2011, Pages 815-825

  Teitelbaum, Jeanne ^a   Ayoub, Omar ^a,c   Skrobik, Yoanna ^b  

^a MCGILL UNIVERSITY   (Canada)

^b MAISONNEUVE ROSEMONT HOSPITAL   (Canada)

^c Aziz University   (Saudi Arabia)

Author keywords

[No Author keywords available]

Indexed keywords

ANALGESIC AGENT; NEUROLEPTIC AGENT; SEDATIVE AGENT;

ANALGESIA; CANADA; CLINICAL PRACTICE; CRITICALLY ILL PATIENT; DELIRIUM; EVIDENCE BASED MEDICINE; HUMAN; INTENSIVE CARE; MEDICAL RESEARCH; NEUROLOGICAL INTENSIVE CARE UNIT; PAIN ASSESSMENT; PRIORITY JOURNAL; PSYCHOMETRY; REVIEW; SEDATION; SYSTEMATIC REVIEW;

EID: 80155142395     PISSN: 03171671     EISSN: None     Source Type: Journal    
DOI: 10.1017/S0317167100012385     Document Type: Review

References (55)

1. Karabinis A, Mandragos K, Stergiopoulos S, et al. Safety and efficacy of analgesia-based sedation with remifentanil versus standard hypnotic-based regimens in intensive care unit patients with brain injuries: a randomised, controlled trial. Crit Care. 2004; 8(4):R268-80.
2. Thomason J, Shintani A, Peterson E, Pun B, Jackson J, Ely E. Intensive care unit delirium is an independent predictor of longer hospital stay: a prospective analysis of 261 non-ventilated patients. Crit Care. 2005; 9(4):R375-81.
3. Lewis KS, Whipple JK, Michael KA, Kebbeman EJ. Effect of analgesic treatment on the physiological consequences of acute pain. Am J Hosp Pharm. 1994; 51:1539-54. (Pubitemid 24186161)
4. Desbiens NA, Wu AW, Broste SK, et al. Pain and satisfaction with pain control in seriously ill hospitalized adults: Findings from the SUPPORT research investigations. For the SUPPORT investigators, Study to Understand Prognoses and Preferences for Outcomes and Risks of Treatment. Crit Care Med. 1996; 24: 1953-61. (Pubitemid 26418886)
5. Marshall J, Finn CA, Theodore AC. Impact of a clinical pharmacist enforced intensive care unit sedation protocol on duration of mechanical ventilation and hospital stay. Crit Care Med. 2008; 36:427-33. (Pubitemid 351158615)
6. Ouimet S, Kavanagh BP, Gottfried SB, Skrobik, Y. Incidence, risk factors and consequences of ICU delirium. Intensive Care Med. 2007;33(8):66-73. (Pubitemid 46115471)
7. Ouimet S, Riker R, Bergeron N, Cossette M, Kavanagh B, Skrobik Y. Subsyndromal delirium in the ICU: evidence for a disease spectrum. Intensive Care Med. 2007;33(6):1007-13. (Pubitemid 46835411)
8. Schnakers C, Chatelle C, VanhaudenhuyseA, et al. The nociception coma scale: a new tool to assess nociception in disorders of consciousness. Pain. 2010; 148(2):215-19.
9. Boly M, Faymonville ME, Schnakers C. Perception of pain in the minimally conscious state with PET activation: an observational study. Lancet Neurol. 2008; 7(11):1013-20.
10. Egerod I, Jensen MB, Herling SF,Welling KL. Effect of an analgosedation protocol for neurointensive patients: a two-phase interventional non-randomized pilot study. Crit Care. 2010; 14 (2):R71.
11. Gélinas C, Arbour C. Behavioral and physiologic indicators during a nociceptive procedure in conscious and unconscious mechanically ventilated adults: similar or different? J Crit Care. 2009; 24(4):628.e7-17.
12. Gélinas C, Johnston C. Pain assessment in the critically ill ventilated adult: validation of the Critical-Care Pain Observation Tool and physiologic indicators. Clin J Pain. 2007; 23(6): 497-505. (Pubitemid 46956186)
13. Riker RR, Picard JT, Fraser GL. Prospective evaluation of the sedation-agitation scale for adult critically ill patients. Crit. Care Med. 1999; 27(7):1325-9. (Pubitemid 29379371)
14. Topolovec-Vranic J, Canzian S, Innis J, Pollmann-Mudryj MA, McFarlan AW, Baker AJ. Patient satisfaction and documentation of pain assessments and management after implementing the adult nonverbal pain scale. Am J Crit Care. 2010; 19(4):345-54.
15. Skrobik Y, Ahern S, Leblanc M, Marquis F, Awissi DK, Kavanagh BP. Protocolized intensive care unit management of analgesia, sedation, and delirium improves analgesia and subsyndromal delirium rates. Anesth Analg. 2010; 111(2): 451-63.
16. Chanques G, Viel E, Constantin JM, et al. The measurement of pain in intensive care unit: Comparison of 5 self-report intensity scales. Pain. 2010; 151(3):711-21.
17. Puntillo KA, Miaskowski C, Kehrle K, Stannard D, Gleeson S, Nye P. Relationship between behavioral and physiological indicators of pain, critical care patients' self-reports of pain, and opioid administration. Crit Care Med. 1997; 25(7):1159-66. (Pubitemid 27310256)
18. Deogaonkar A, Gupta R, DeGeorgia M, et al. Bispectral Index monitoring correlates with sedation scales in brain-injured patients. Crit Care Med. 2004; 32(12):2403-6. (Pubitemid 39648220)
19. Glass P, Bloom M, Kearse L, Rosow C, Sebel P, Manberg P. The sedation level and effects on memory of propofol, midazolam, isoflurane, and alfentanil in healthy volunteers. Anesthesiology. 1997; 86(4):836-47. (Pubitemid 27174724)
20. Sessler CN, Gosnell M, Grap MJ, et al. The Richmond agitationsedation scale: validity and reliability in adult intensive care patients. Am J Respir Crit Care Med. 2002; 166(10):1338-44. (Pubitemid 35292699)
21. Teasdale G, Jennett B. Assessment and prognosis of coma after head injury. Acta Neurochirgica (Wien). 1976; 34(1-4):45-55.
22. Olson DM, Thoyre SM, Peterson ED, Graffagnino C.Arandomized evaluation of bispectral index-augmented sedation assessment in neurological patients. Neurocrit Care. 2009; 11(1):20-7.
23. Hansen-Flaschen J, Cowen J, Polomano RC. Beyond the Ramsay scale: need for a validated measure of sedating drug efficacy in the intensive care unit. Crit Care Med. 1994; 22(5):732-3. (Pubitemid 24151063)
24. Ramsay MA, Savege TM, Simpson BR, Goodwin R. Controlled sedation with alphaxalone-alphadolone. Br Med J. 1974; 22;2 (5920):656-9.
25. Bergeron N, Dubois MJ, Dumont M, Dial S, Skrobik Y. Intensive Care Delirium Screening Checklist: evaluation of a new screening tool. Intensive Care Med. 2001; 27(5):859-64. (Pubitemid 32480514)
26. Van Rompaey B, Elseviers MM, Schuurmans MJ, Shortridge-Baggett LM, Truijen S, Bossaert L. Risk factors for delirium in intensive care patients: a prospective cohort study. Crit Care. 2009; 13(3):R77.
27. Ouimet S, Kavanagh BP, Gottfried SB, Skrobik Y. Incidence, risk factors and consequences of ICU delirium. Intensive Care Med. 2007; 33(1):66-73. (Pubitemid 46115471)
28. Guyatt GH, Oxman AD, Vist GE, et al. GRADE: an emerging consensus on rating quality of evidence and strength of recommendations. BMJ. 2008; 26;336(7650):924-6. (Pubitemid 351632017)
29. Ouimet S, Riker R, Bergeron N, Cossette M, Kavanagh B, Skrobik Y. Subsyndromal delirium in the ICU: evidence for a disease spectrum. Intensive Care Med. 2007; 33(6):1007-13. (Pubitemid 46835411)
30. Pandharipande P, Shintani A, Peterson J, et al. Lorazepam is an independent risk factor for transitioning to delirium in intensive care unit patients. Anesthesiology. 2006; 104(1):21-6.
31. Cochen V, Arnulf I, Demeret S, et al. Vivid dreams, hallucinations, psychosis and REM sleep in Guillain-Barré syndrome. Brain. 2005; 128(11):2535-45. (Pubitemid 41552939)
32. Caeiro L, Menger C, Ferro JM, Albuquerque R, Figueira ML. Delirium in acute subarachnoid haemorrhage. Cerebrovasc Dis. 2005; 19(1):31-8. (Pubitemid 40082256)
33. Reijneveld JC, Wermer M, Boonman Z, van Gijn J, Rinkel GJE. Acute confusional state as presenting feature in aneurysmal subarachnoid haemorrhage: Frequency and characteristics. J Neurol. 2000; 247(2):112-16. (Pubitemid 30162525)
34. Gustafson Y, Olsson T, Erikkson S, Bucht G. Acute confusional state (delirium) in stroke patients. Cerebrovasc Dis. 1991; 1: 257-64.
35. Hénon H, Lebert F, Durieu I, et al. Confusional state in stroke: relation to preexisting dementia, patient characteristics, and outcome. Stroke. 1999; 30(4):773-9. (Pubitemid 29156367)
36. Caeiro L, Ferro JM, Albuquerque R, Figueira ML: Delirium in the first days of acute stroke. J Neurol. 2004; 251(2):171-8. (Pubitemid 38221630)
37. Ramirez-Bermudez J, Lopez-Gómez M, Sosa Ana L, Aceves S, Nader-Kawachi J, Nicolini H. Frequency of delirium in a neurological emergency room. J Neuropsychiatry Clin Neurosci. 2006; 18(1):108-12. (Pubitemid 43277264)
38. Engelhard K, Reeker W, Kochs E, Werner C. Effect of remifentanil on intracranial pressure and cerebral blood flow velocity in patients with head trauma. Acta Anaesthesiol Scand. 2004; 48 (4):396-9. (Pubitemid 38523542)
39. Albanese J, Durbec O, Viviand X, Potie F, Alliez B, Martin C. Sufentanil increases intracranial pressure in patients with head trauma. Anesthesiology. 1993; 79(3):493-7. (Pubitemid 23263693)
40. Albanèse J, Viviand X, Potie F, Rey M, Alliez B, Martin C. Sufentanil, fentanyl, and alfentanil in head trauma patients: a study on cerebral hemodynamics. Crit Care Med. 1999;27(2): 407-11. (Pubitemid 29113553)
41. Albanèse J, Arnaud S, Rey M, Thomachot L, Alliez B, Martin C. Ketamine decreases intracranial pressure and electroencephalographic activity in traumatic brain injury patients during propofol sedation. Anesthesiology. 1997; 87(6):1328-34. (Pubitemid 28007328)
42. Kolenda H, Gremmelt A, Rading S, Braun U, Markakis E. Ketamine for analgosedative therapy in intensive care treatment of head-injured patients. Acta Neurochir (Wien). 1996; 138(10): 1193-9. (Pubitemid 26355814)
43. Bourgoin A, Albanèse J, Léone M, Sampol-Manos E, Viviand X, Martin C. Effects of sufentanil or ketamine administered in target-controlled infusion on the cerebral hemodynamics of severely brain-injured patients. Crit Care Med. 2005; 33(5): 1109-13.
44. Watling SM, Dasta JF, Seidl EC. Sedatives, analgesics, and paralytics in the ICU. Ann Pharmacother. 1997; 31(2):148-53. (Pubitemid 27074098)
45. Rapanos T, Murphy P, Szalai JP, Burlacoff L, Lam-McCulloch J, Kay J. Rectal indomethacin reduces postoperative pain and morphine use after cardiac surgery. Can J Anaesth. 1999; 46(8): 725-30. (Pubitemid 29426462)
46. Hynninen MS, Cheng DC, Hossain I, et al. Non-steroidal antiinflammatory drugs in treatment of postoperative pain after cardiac surgery. Can J Anaesth. 2000; 47(12):1182-7. (Pubitemid 32098993)
47. Marinella MA. Propofol for sedation in the intensive care unit: essentials for the clinician. Respir Med. 1997; 91(9): 505-10. (Pubitemid 27397290)
48. Farling PA, Johnston JR, Coppel DL. Propofol infusion for sedation of patients with head injury in intensive care. A preliminary report. Anaesthesia. 1989; 44(3):222-6. (Pubitemid 19097192)
49. JohnstonAJ, Steiner LA, Chatfield DA, et al. Effects of propofol on cerebral oxygenation and metabolism after head injury. Br J Anaesth. 2003; 91(6):781-6. (Pubitemid 37508816)
50. Aryan HE, Box KW, Ibrahim D, Desiraju U, Ames CP. Safety and efficacy of dexmedetomidine in neurosurgical patients. Brain Inj. 2006; 20(8):791-8. (Pubitemid 44594159)
51. Grof TM, Bledsoe KA. Evaluating the use of dexmedetomidine in neurocritical care patients. Neurocrit Care. 2010; 12(3):356-61.
52. Mirski MA, Lewin JJ 3rd, Ledroux S, et al. Cognitive improvement during continuous sedation in critically ill, awake and responsive patients: the acute neurological ICU sedation trial (ANIST). Neurocrit Care. 2010; 12(3):356-61.
53. Chanques G, Viel E, Constantin JM, et al. The measurement of pain in intensive care unit: comparison of 5 self-report intensity scales. Pain. 2010; 151(3):711-21.
54. Devlin JW, Roberts RJ, Fong JJ, et al. Efficacy and safety of quetiapine in critically ill patients with delirium: a prospective, multicenter, randomized, double-blind, placebo-controlled pilot study. Crit Care Med. 2010; 38(2):419-27.
55. Savard M, Al Thenayan E, Norton L, Sharpe MD, Young GB. Continuous EEG monitoring in severe Guillain-Barré syndrome patients J Clin Neurophysiol. 2009; 26(1):21-3.